Upper Extremity Life Care Specialist (LCS)

NCT05422014 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 117

Last updated 2026-08-31

No results posted yet for this study

Summary

This is a randomized control trial aimed at learning more about LCS position and the value it provides to the patient's who have sustained upper extremity traumas.

Conditions

  • Upper Extremity Trauma

Interventions

BEHAVIORAL

Life Care Specialist (LCS)

Life Care Specialist (LCS) will : * Provide patients with individualized risk assessment for opioid misuse. * Act as patient's "Pain Coach." Providing targeted education and behavior-based pain treatment options. * Train and provide CWC evidence based non-pharmaceutical pain management techniques, using the Community Resiliency Model. * Use the Opioid Risk Tool (ORT) as the method to identity the risk of substance misuse. * Provide education, support and resources, as well as local, state, and national resources to enhance the whole health aspect of the position. These resources include but are not limited to: written documents that outline the key concepts of the pain management techniques taught by the LCS and a list of hotlines and websites. * LCS, when applicable, will provide education for caretakers on the risk of opioid use and the non -pharmaceutical pain management protocol. * Provide follow up for all patients in intervention group.

Sponsors & Collaborators

  • American Society for Surgery of the Hand

    collaborator OTHER
  • Ruth Jackson Orthopaedic Society

    collaborator UNKNOWN
  • Emory University

    lead OTHER

Principal Investigators

  • Nicole Zelenski, MD · Emory University

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-10-17
Primary Completion
2025-05-23
Completion
2025-08-01

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05422014 on ClinicalTrials.gov